Revenue: The sum of all revenue fields included for a company's operating activities.
Novartis AG (NVS) had Revenue of $15.03B for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
|
Revenue |
$15.03B |
$1.20B |
|
$3.61B |
|
$11.42B |
|
$13.19B |
|
$1.84B |
|
$-526.00M |
|
$1.32B |
|
$1.32B |
|
$1.20B |
|
$1.20B |
|
$1.20B |
|
$1.20B |
|
$1.84B |
|
$5.39B |
|
1.90B |
|
1.91B |
|
$0.63 |
|
$0.63 |
|
| Balance Sheet Financials | |
$28.75B |
|
$10.62B |
|
$88.40B |
|
$117.15B |
|
$32.52B |
|
$36.70B |
|
$47.06B |
|
$79.58B |
|
$37.56B |
|
$-29.44B |
|
$37.56B |
|
-- |
|
| Cash Flow Statement Financials | |
$15.06B |
|
$-16.59B |
|
$-905.00M |
|
$11.44B |
|
$8.87B |
|
$-2.56B |
|
$837.00M |
|
$-9.07B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.88 |
|
-- |
|
-- |
|
0.49 |
|
1.23 |
|
75.99% |
|
12.26% |
|
12.26% |
|
-- |
|
8.76% |
|
8.00% |
|
$14.03B |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.59 |
|
1.51 |
|
59.66 |
|
3.18% |
|
-4.06% |
|
1.02% |
|
1.61% |
|
-- |
|
$7.37 |
|
$7.91 |
|